Friday, 1 November 2013

Recommended HIV Treatment Regimens

BEING HUMAN MEANS A SIMPLE LIFE WITH GOOD FAITH AND ACTION

Recommended HIV Treatment Regimens



Recommended HIV Treatment Regimens
What is the treatment for HIV?
Antiretroviral therapy (ART)
is the recommended
treatment for HIV. ART involves taking a combination of
anti-HIV medications (a
regimen
) every day. Anti-HIV
medications (also called
antiretrovirals
) are grouped into six
drug classes
according to how they ght HIV. e six classes
are non-nucleoside reverse transcriptase inhibitors
(NNRTIs), nucleoside reverse transcriptase inhibitors
(NRTIs), protease inhibitors (PIs), fusion inhibitors, CCR5
antagonists, and integrase inhibitors.
Recommended HIV treatment regimens include three or
more anti-HIV medications from at least two dierent drug
classes. Taking a combination of anti-HIV medications from
dierent classes is the most eective way to control the virus.
Some anti-HIV medications are available in combination
(two or more medications in one pill).
Anti-HIV medications are approved by the U.S. Food and
Drug Administration (FDA). See the
FDA-Approved Anti-
HIV Medications
fact sheet for a complete list of
medications used in HIV treatment regimens in the United
States.
How will I know which anti-HIV medications
to take?
e best combination of anti-HIV medications for you
depends on your individual needs. Factors that you and your
health care provider will consider when selecting your HIV
regimen include:
Other diseases or conditions you may have
Possible side eects of anti-HIV medications
e risk of interactions between anti-HIV medications and
other medications you take
Results of
drug-resistance testing
and other tests
Convenience of the regimen. (For example, a regimen that
involves taking only one pill a day is convenient to follow.)
Any personal issues that can make following a regimen
di

cult (such as depression or alcohol or drug abuse)
• If you’re not already a subscriber,
request a free subscription to our
gods-word by gaurav pawar daily artical -magazine
The Good News at         



• While you’re at it, also request a
free subscription to our
World News
and good-nwse
newsletter 

No comments: